3-(2-Eth­oxy-2-oxoeth­yl)-4,5,6,7,8,9-hexa­hydrocyclo­octa­[d][1,2,3]selena­diazol-3-ium bromide

Dieter Schollmeyer; Heiner Detert

doi:10.1107/S2414314625001439

. 2025 Feb 28;10(Pt 2):x250143. doi: 10.1107/S2414314625001439

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide

Dieter Schollmeyer ^a, Heiner Detert ^a,^*

Editor: M Bolte^b

PMCID: PMC11904625 PMID: 40092355

The title compound features a selenadiazole five-membered ring attached to a cyclooctene ring. A bromine anion is located in the vicinity of the selenium atom [3.0197 (5) Å].

Keywords: crystal structure, selenium, heterocycle, medium-sized ring

Abstract

The title compound, C₁₂H₁₉N₂O₂Se⁺·Br⁻, features a selenadiazole five-membered ring attached to a cyclooctene ring. A bromine anion is located in the vicinity of the selenium atom [3.0197 (5) Å]

Structure description

1,2,3-Selenadiazoles are known as precursors for alkynes, especially strained cycloalkynes (Bissinger et al., 1988 ▸; Detert & Meier, 1997 ▸). Jaffari et al. (1970 ▸) reported benzo-annulated selenadiazolium salts, and the first 1,2,3-selenadiazolium salt was described by Butler & Fox (2001 ▸). Recently, N-methylated selenadiazoles were characterized by us (Schollmeyer & Detert, 2016 ▸, 2017 ▸).

The molecular structure of the title compound (Fig. 1 ▸) is composed of a cyclooctene ring with a boat-twist conformation, a 1,2,3-selenadiazole ring, an ethylacetate unit, and a bromide anion in the vicinity of the selenium atom. The selenadiazole ring is planar with a maximum deviation of 0.018 (3) Å from the mean plane at N2 whereas N3 is slightly below the ring. In spite of the conformational freedom, the ester unit, C12–C17, is almost planar; here the maximum deviation from the mean plane is 0.117 (2) Å at O15. These planes subtend a dihedral angle of 77.24 (14)°. The cyclooctene ring adopts a distorted boat-chair conformation (Evans & Boeyens, 1988 ▸). The bromide ion is located in the vicinity of the selenium atom [3.0197 (5) Å], opposite to the carbonyl group and slightly below the selenadiazole plane [0.5364 (3) Å]. The packing is shown in Fig. 2 ▸.

View (Macrae *et al.*, 2020 ▸) of the title compound. Displacement ellipsoids are drawn at the 50% probability level.

Part of the packing diagram. View along a-axis direction (Spek, 2020 ▸).

Synthesis and crystallization

The title compound was prepared by adding ethyl bromoacetate (2.5 ml) to a solution of cycloocteno-1,2,3-selenadiazole (0.9 g, 4 mmol) (Meier & Voigt, 1972 ▸) in nitromethane (12 ml). The mixture was kept for one month at room temperature under exclusion of light. Two isomeric selenadiazolium salts in a 2.5:1 ratio were formed (¹H-NMR), the main isomer was isolated by evaporation of the solvent and chromatography on silica gel using chloroform/propanol-2 as eluent. Yield: 0.65 g of the pure title compound (43%), m.p.: 435 K. IR (KBr): 2975, 2912, 2855, 1733, 1711, 1522, 1472, 1447, 1368, 1339, 1240, 1220, 1022 cm⁻¹.¹H-NMR (CDCl₃, 400 MHz): 5.63 (s, 2 H, N—CH₂; ¹³C-satellites, J = 148 Hz), 4.26, (q, J = 7.5 Hz, OCH₂), 3.75 (pseudo-t, 2 H, 10-CH₂), 3.17 (pseudo-t, 2 H, 5-CH₂), 1.90 (qui, 2 H, 9-CH₂), 1.78 (qui, 2 H, 6-CH₂), 1.40 (m, 4 H, CH₂), 1.26 ppm (t, 3 H, CH₃). NOE: Irradiation into 5.63: positive NOE at 3.17, 1.78 ppm. 175.6 (C11, Se-satellites, ¹J_C–Se = 160 Hz), 164.0 (C=O), 154.4 (C-4) 64.4 (OCH₂), 61.0 (NCH₂), 31.2 (C-9), 30.5 (C-10), 28.2 (C-6), 26.8 (C-5), 25.6 (C-7), 24.8 (C-7), 13.9 (CH₃) ppm. Numbering of atoms according to scheme 1. MS: (EI): 685 (19%, Se₂Br-isotope pattern), (C₁₂H₁₉O₂N₂Se)₂Br⁺); 381 (4%, M+).

Refinement

Crystal data, data collection and structure refinement details are summarized in Table 1 ▸.

Table 1. Experimental details.

Crystal data
Chemical formula	C₁₂H₁₉N₂O₂Se⁺·Br⁻
M _r	382.16
Crystal system, space group	Triclinic, P
Temperature (K)	120
a, b, c (Å)	8.4924 (7), 9.3927 (7), 9.7799 (8)
α, β, γ (°)	71.379 (6), 86.439 (7), 74.119 (6)
V (Å³)	710.78 (10)
Z	2
Radiation type	Mo Kα
μ (mm⁻¹)	5.45
Crystal size (mm)	0.37 × 0.35 × 0.18

Data collection
Diffractometer	Stoe IPDS 2T
Absorption correction	Integration [X-RED32 (Stoe, & Cie, 2020 ▸), absorption correction by Gaussian integration, analogous to Coppens (1970 ▸)]
T_min, T_max	0.163, 0.405
No. of measured, independent and observed [I > 2σ(I)] reflections	6548, 3370, 3085
R _int	0.030
(sin θ/λ)_max (Å⁻¹)	0.659

Refinement
R[F² > 2σ(F²)], wR(F²), S	0.035, 0.096, 1.10
No. of reflections	3370
No. of parameters	164
H-atom treatment	H-atom parameters constrained
Δρ_max, Δρ_min (e Å⁻³)	1.39, −0.84

Open in a new tab

Computer programs: X-AREA WinXpose, Recipe, Integrate (Stoe & Cie, 2020 ▸), SHELXT2014 (Sheldrick, 2015a ▸), SHELXL2019/3 (Sheldrick, 2015b ▸), PLATON (Spek, 2020 ▸) and Mercury (Macrae et al., 2020 ▸).

Supplementary Material

Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S2414314625001439/bt4164sup1.cif

x-10-x250143-sup1.cif^{(233.9KB, cif)}

Structure factors: contains datablock(s) I. DOI: 10.1107/S2414314625001439/bt4164Isup2.hkl

x-10-x250143-Isup2.hkl^{(268.9KB, hkl)}

x-10-x250143-Isup3.cml^{(5.5KB, cml)}

Supporting information file. DOI: 10.1107/S2414314625001439/bt4164Isup3.cml

CCDC reference: 2424352

Additional supporting information: crystallographic information; 3D view; checkCIF report

full crystallographic data

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Crystal data

C₁₂H₁₉N₂O₂Se⁺·Br⁻	F(000) = 380
M_r = 382.16	D_x = 1.786 Mg m⁻³
Triclinic, P1	Melting point: 435 K
a = 8.4924 (7) Å	Mo Kα radiation, λ = 0.71073 Å
b = 9.3927 (7) Å	Cell parameters from 10409 reflections
c = 9.7799 (8) Å	θ = 2.5–28.4°
α = 71.379 (6)°	µ = 5.45 mm⁻¹
β = 86.439 (7)°	T = 120 K
γ = 74.119 (6)°	Block, colorless
V = 710.78 (10) Å³	0.37 × 0.35 × 0.18 mm
Z = 2

Open in a new tab

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Data collection

Stoe IPDS 2T diffractometer	3370 independent reflections
Radiation source: sealed X-ray tube, 12x0.4mm long-fine focus	3085 reflections with I > 2σ(I)
Detector resolution: 6.67 pixels mm^-1	R_int = 0.030
rotation method, ω scans	θ_max = 27.9°, θ_min = 2.5°
Absorption correction: integration [X-Red32 (Stoe, & Cie, 2020), absorption correction by Gaussian integration, analogous to Coppens (1970)]	h = −9→11
T_min = 0.163, T_max = 0.405	k = −12→12
6548 measured reflections	l = −12→12

Open in a new tab

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Refinement

Refinement on F²	Primary atom site location: dual
Least-squares matrix: full	Hydrogen site location: inferred from neighbouring sites
R[F² > 2σ(F²)] = 0.035	H-atom parameters constrained
wR(F²) = 0.096	w = 1/[σ²(F_o²) + (0.0549P)² + 1.110P] where P = (F_o² + 2F_c²)/3
S = 1.10	(Δ/σ)_max = 0.001
3370 reflections	Δρ_max = 1.39 e Å⁻³
164 parameters	Δρ_min = −0.84 e Å⁻³
0 restraints

Open in a new tab

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

Refinement. Hydrogen atoms were refined as riding on their parent atoms with C—H = 0.99 Å for methylene groups and with C—H = 0.98 Å for methyl groups. Isotropic displacement parameters of the H atoms were set to 1.2U_eq(C) or 1.5U_eq(C_methyl).

Open in a new tab

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å²)

	x	y	z	U_iso*/U_eq
Br1	0.49934 (4)	0.22173 (3)	1.21107 (3)	0.02302 (10)
Se1	0.34890 (3)	0.21865 (3)	0.94061 (3)	0.01662 (10)
O14	0.1838 (3)	0.4488 (2)	0.4557 (2)	0.0206 (4)
O15	0.0967 (3)	0.2826 (2)	0.3758 (2)	0.0178 (4)
N2	0.2602 (3)	0.1785 (3)	0.7980 (3)	0.0173 (5)
N3	0.3497 (3)	0.2043 (3)	0.6843 (3)	0.0144 (4)
C4	0.4827 (3)	0.2615 (3)	0.6848 (3)	0.0143 (5)
C5	0.5890 (3)	0.2910 (3)	0.5563 (3)	0.0164 (5)
H5A	0.626019	0.384490	0.548184	0.020*
H5B	0.522922	0.313715	0.468181	0.020*
C6	0.7403 (4)	0.1532 (3)	0.5634 (3)	0.0187 (5)
H6A	0.704205	0.056317	0.590697	0.022*
H6B	0.785283	0.168197	0.465499	0.022*
C7	0.8790 (3)	0.1298 (3)	0.6690 (3)	0.0197 (6)
H7A	0.977802	0.055683	0.648121	0.024*
H7B	0.905037	0.230735	0.650026	0.024*
C8	0.8431 (4)	0.0691 (3)	0.8295 (3)	0.0191 (5)
H8A	0.940889	−0.013424	0.878496	0.023*
H8B	0.752247	0.019621	0.838569	0.023*
C9	0.7976 (3)	0.1894 (3)	0.9106 (3)	0.0187 (5)
H9A	0.893461	0.229792	0.911700	0.022*
H9B	0.776542	0.135081	1.012018	0.022*
C10	0.6482 (3)	0.3294 (3)	0.8502 (3)	0.0163 (5)
H10A	0.614406	0.385169	0.922162	0.020*
H10B	0.679218	0.402734	0.761909	0.020*
C11	0.5076 (3)	0.2798 (3)	0.8151 (3)	0.0139 (5)
C12	0.2965 (3)	0.1714 (3)	0.5601 (3)	0.0167 (5)
H12A	0.237092	0.089818	0.594280	0.020*
H12B	0.393413	0.131917	0.507588	0.020*
C13	0.1851 (3)	0.3189 (3)	0.4589 (3)	0.0161 (5)
C16	−0.0031 (4)	0.4150 (4)	0.2620 (4)	0.0263 (7)
H16A	0.064370	0.484369	0.207894	0.032*
H16B	−0.094754	0.476150	0.304881	0.032*
C17	−0.0676 (4)	0.3498 (4)	0.1638 (4)	0.0245 (6)
H17A	−0.131725	0.435342	0.084350	0.037*
H17B	−0.137472	0.284484	0.217717	0.037*
H17C	0.024140	0.286559	0.124624	0.037*

Open in a new tab

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Atomic displacement parameters (Å²)

	U¹¹	U²²	U³³	U¹²	U¹³	U²³
Br1	0.02640 (17)	0.02727 (17)	0.01503 (16)	−0.00549 (12)	0.00133 (12)	−0.00775 (12)
Se1	0.01565 (15)	0.02022 (16)	0.01349 (16)	−0.00509 (11)	0.00309 (10)	−0.00490 (11)
O14	0.0246 (10)	0.0171 (9)	0.0214 (10)	−0.0071 (8)	−0.0009 (8)	−0.0062 (8)
O15	0.0195 (10)	0.0160 (9)	0.0174 (10)	−0.0055 (8)	−0.0041 (8)	−0.0030 (8)
N2	0.0151 (11)	0.0218 (11)	0.0152 (11)	−0.0053 (9)	0.0007 (9)	−0.0056 (9)
N3	0.0135 (10)	0.0147 (10)	0.0158 (11)	−0.0046 (8)	0.0007 (8)	−0.0050 (8)
C4	0.0124 (11)	0.0122 (11)	0.0166 (12)	−0.0033 (9)	0.0003 (9)	−0.0021 (9)
C5	0.0161 (12)	0.0181 (12)	0.0147 (13)	−0.0068 (10)	0.0014 (10)	−0.0032 (10)
C6	0.0173 (12)	0.0230 (13)	0.0172 (13)	−0.0063 (11)	0.0046 (10)	−0.0081 (11)
C7	0.0139 (12)	0.0205 (13)	0.0232 (15)	−0.0033 (10)	0.0026 (11)	−0.0062 (11)
C8	0.0179 (13)	0.0187 (13)	0.0173 (13)	−0.0028 (10)	−0.0016 (10)	−0.0027 (10)
C9	0.0163 (12)	0.0225 (13)	0.0173 (13)	−0.0046 (10)	−0.0031 (10)	−0.0060 (11)
C10	0.0178 (12)	0.0155 (12)	0.0169 (13)	−0.0060 (10)	−0.0007 (10)	−0.0053 (10)
C11	0.0149 (12)	0.0117 (11)	0.0138 (12)	−0.0025 (9)	0.0022 (9)	−0.0037 (9)
C12	0.0184 (13)	0.0168 (12)	0.0173 (13)	−0.0061 (10)	0.0002 (10)	−0.0074 (10)
C13	0.0170 (12)	0.0194 (12)	0.0145 (12)	−0.0088 (10)	0.0033 (10)	−0.0059 (10)
C16	0.0371 (17)	0.0187 (13)	0.0204 (15)	−0.0025 (12)	−0.0127 (13)	−0.0043 (11)
C17	0.0245 (15)	0.0270 (15)	0.0213 (15)	−0.0055 (12)	−0.0067 (12)	−0.0064 (12)

Open in a new tab

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Geometric parameters (Å, º)

Se1—N2	1.811 (3)	C8—C9	1.533 (4)
Se1—C11	1.850 (3)	C8—H8A	0.9900
O14—C13	1.208 (3)	C8—H8B	0.9900
O15—C13	1.316 (3)	C9—C10	1.541 (4)
O15—C16	1.469 (4)	C9—H9A	0.9900
N2—N3	1.303 (3)	C9—H9B	0.9900
N3—C4	1.378 (3)	C10—C11	1.490 (4)
N3—C12	1.470 (4)	C10—H10A	0.9900
C4—C11	1.375 (4)	C10—H10B	0.9900
C4—C5	1.498 (4)	C12—C13	1.523 (4)
C5—C6	1.541 (4)	C12—H12A	0.9900
C5—H5A	0.9900	C12—H12B	0.9900
C5—H5B	0.9900	C16—C17	1.491 (4)
C6—C7	1.538 (4)	C16—H16A	0.9900
C6—H6A	0.9900	C16—H16B	0.9900
C6—H6B	0.9900	C17—H17A	0.9800
C7—C8	1.532 (4)	C17—H17B	0.9800
C7—H7A	0.9900	C17—H17C	0.9800
C7—H7B	0.9900

N2—Se1—C11	89.04 (12)	C10—C9—H9A	108.2
C13—O15—C16	115.5 (2)	C8—C9—H9B	108.2
N3—N2—Se1	109.05 (18)	C10—C9—H9B	108.2
N2—N3—C4	120.2 (2)	H9A—C9—H9B	107.4
N2—N3—C12	115.6 (2)	C11—C10—C9	111.8 (2)
C4—N3—C12	124.2 (2)	C11—C10—H10A	109.3
C11—C4—N3	112.7 (2)	C9—C10—H10A	109.3
C11—C4—C5	125.8 (2)	C11—C10—H10B	109.3
N3—C4—C5	121.5 (2)	C9—C10—H10B	109.3
C4—C5—C6	113.5 (2)	H10A—C10—H10B	107.9
C4—C5—H5A	108.9	C4—C11—C10	124.5 (2)
C6—C5—H5A	108.9	C4—C11—Se1	109.0 (2)
C4—C5—H5B	108.9	C10—C11—Se1	126.3 (2)
C6—C5—H5B	108.9	N3—C12—C13	110.1 (2)
H5A—C5—H5B	107.7	N3—C12—H12A	109.6
C7—C6—C5	115.8 (2)	C13—C12—H12A	109.6
C7—C6—H6A	108.3	N3—C12—H12B	109.6
C5—C6—H6A	108.3	C13—C12—H12B	109.6
C7—C6—H6B	108.3	H12A—C12—H12B	108.2
C5—C6—H6B	108.3	O14—C13—O15	126.4 (3)
H6A—C6—H6B	107.4	O14—C13—C12	123.5 (3)
C8—C7—C6	115.6 (2)	O15—C13—C12	110.1 (2)
C8—C7—H7A	108.4	O15—C16—C17	107.3 (2)
C6—C7—H7A	108.4	O15—C16—H16A	110.3
C8—C7—H7B	108.4	C17—C16—H16A	110.3
C6—C7—H7B	108.4	O15—C16—H16B	110.3
H7A—C7—H7B	107.4	C17—C16—H16B	110.3
C7—C8—C9	116.7 (2)	H16A—C16—H16B	108.5
C7—C8—H8A	108.1	C16—C17—H17A	109.5
C9—C8—H8A	108.1	C16—C17—H17B	109.5
C7—C8—H8B	108.1	H17A—C17—H17B	109.5
C9—C8—H8B	108.1	C16—C17—H17C	109.5
H8A—C8—H8B	107.3	H17A—C17—H17C	109.5
C8—C9—C10	116.3 (2)	H17B—C17—H17C	109.5
C8—C9—H9A	108.2

C11—Se1—N2—N3	2.47 (19)	C5—C4—C11—C10	−1.3 (4)
Se1—N2—N3—C4	−3.2 (3)	N3—C4—C11—Se1	0.0 (3)
Se1—N2—N3—C12	177.90 (18)	C5—C4—C11—Se1	−177.0 (2)
N2—N3—C4—C11	2.2 (4)	C9—C10—C11—C4	−87.9 (3)
C12—N3—C4—C11	−179.0 (2)	C9—C10—C11—Se1	87.2 (3)
N2—N3—C4—C5	179.4 (2)	N2—Se1—C11—C4	−1.4 (2)
C12—N3—C4—C5	−1.8 (4)	N2—Se1—C11—C10	−177.1 (2)
C11—C4—C5—C6	82.8 (3)	N2—N3—C12—C13	93.4 (3)
N3—C4—C5—C6	−94.1 (3)	C4—N3—C12—C13	−85.5 (3)
C4—C5—C6—C7	−74.3 (3)	C16—O15—C13—O14	4.8 (4)
C5—C6—C7—C8	71.2 (3)	C16—O15—C13—C12	−173.6 (2)
C6—C7—C8—C9	−102.0 (3)	N3—C12—C13—O14	21.8 (4)
C7—C8—C9—C10	57.4 (3)	N3—C12—C13—O15	−159.8 (2)
C8—C9—C10—C11	45.7 (3)	C13—O15—C16—C17	169.4 (3)
N3—C4—C11—C10	175.8 (2)

Open in a new tab

References

Bissinger, H.-J., Detert, H. & Meier, H. (1988). Liebigs Ann. Chem. pp. 221–224.
Butler, R. N. & Fox, A. (2001). J. Chem. Soc. Perkin Trans. 1, pp. 394–397.
Coppens, P. (1970). Crystallographic Computing, edited by F. R. Ahmed, S. R. Hall & C. P. Huber, pp. 255–270. Copenhagen: Munksgaard.
Detert, H. & Meier, H. (1997). Liebigs Ann. Recl, pp. 1557–1563.
Evans, D. G. & Boeyens, J. C. A. (1988). Acta Cryst. B44, 663–671.
Jaffari, G. A., Nunn, A. J. & Ralph, J. T. (1970). J. Chem. Soc. C, pp. 2060–2062.
Macrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M. & Wood, P. A. (2020). J. Appl. Cryst.53, 226–235. [DOI] [PMC free article] [PubMed]
Meier, H. & Voigt, E. (1972). Tetrahedron, 28, 187–198.
Schollmeyer, D. & Detert, H. (2016). IUCrData, 1, x161950.
Schollmeyer, D. & Detert, H. (2017). IUCrData, 2, x170167.
Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.
Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.
Spek, A. L. (2020). Acta Cryst. E76, 1–11. [DOI] [PMC free article] [PubMed]
Stoe & Cie (2020). X-RED and X-AREA. Stoe & Cie, Darmstadt, Germany.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I, global. DOI: 10.1107/S2414314625001439/bt4164sup1.cif

x-10-x250143-sup1.cif^{(233.9KB, cif)}

Structure factors: contains datablock(s) I. DOI: 10.1107/S2414314625001439/bt4164Isup2.hkl

x-10-x250143-Isup2.hkl^{(268.9KB, hkl)}

x-10-x250143-Isup3.cml^{(5.5KB, cml)}

Supporting information file. DOI: 10.1107/S2414314625001439/bt4164Isup3.cml

CCDC reference: 2424352

Additional supporting information: crystallographic information; 3D view; checkCIF report

[bb1] Bissinger, H.-J., Detert, H. & Meier, H. (1988). Liebigs Ann. Chem. pp. 221–224.

[bb2] Butler, R. N. & Fox, A. (2001). J. Chem. Soc. Perkin Trans. 1, pp. 394–397.

[bb3] Coppens, P. (1970). Crystallographic Computing, edited by F. R. Ahmed, S. R. Hall & C. P. Huber, pp. 255–270. Copenhagen: Munksgaard.

[bb4] Detert, H. & Meier, H. (1997). Liebigs Ann. Recl, pp. 1557–1563.

[bb15] Evans, D. G. & Boeyens, J. C. A. (1988). Acta Cryst. B44, 663–671.

[bb5] Jaffari, G. A., Nunn, A. J. & Ralph, J. T. (1970). J. Chem. Soc. C, pp. 2060–2062.

[bb6] Macrae, C. F., Sovago, I., Cottrell, S. J., Galek, P. T. A., McCabe, P., Pidcock, E., Platings, M., Shields, G. P., Stevens, J. S., Towler, M. & Wood, P. A. (2020). J. Appl. Cryst.53, 226–235. [DOI] [PMC free article] [PubMed]

[bb7] Meier, H. & Voigt, E. (1972). Tetrahedron, 28, 187–198.

[bb8] Schollmeyer, D. & Detert, H. (2016). IUCrData, 1, x161950.

[bb9] Schollmeyer, D. & Detert, H. (2017). IUCrData, 2, x170167.

[bb10] Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.

[bb11] Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.

[bb12] Spek, A. L. (2020). Acta Cryst. E76, 1–11. [DOI] [PMC free article] [PubMed]

[bb13] Stoe & Cie (2020). X-RED and X-AREA. Stoe & Cie, Darmstadt, Germany.

PERMALINK

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide

Dieter Schollmeyer

Heiner Detert

Roles

Abstract

Structure description

Figure 1.

Figure 2.

Synthesis and crystallization

Refinement

Table 1. Experimental details.

Supplementary Material

full crystallographic data

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Crystal data

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Data collection

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Refinement

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Special details

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å²)

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Atomic displacement parameters (Å²)

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Geometric parameters (Å, º)

References

Associated Data

Supplementary Materials

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

3-(2-Eth­oxy-2-oxoeth­yl)-4,5,6,7,8,9-hexa­hydrocyclo­octa­[d][1,2,3]selena­diazol-3-ium bromide

Dieter Schollmeyer

Heiner Detert

Roles

Abstract

Structure description

Figure 1.

Figure 2.

Synthesis and crystallization

Refinement

Table 1. Experimental details.

Supplementary Material

full crystallographic data

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Crystal data

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Data collection

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Refinement

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Special details

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Atomic displacement parameters (Å2)

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Geometric parameters (Å, º)

References

Associated Data

Supplementary Materials

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å²)

3-(2-Ethoxy-2-oxoethyl)-4,5,6,7,8,9-hexahydrocycloocta[d][1,2,3]selenadiazol-3-ium bromide . Atomic displacement parameters (Å²)